Vial size Match the vial mg on the label to the vial mg you plan to enter into the calculator
Semaglutide mainly targets the GLP-1 receptor , while retatrutide is a triple agonist that targets GLP-1, GIP, and glucagon receptors
Some research investigates transdermal delivery of small-molecule GLP-1 receptor agonists or modified peptides, but these remain in early development stages
Key administration details for compounded tirzepatide: Subcutaneous injection, once weekly Rotate injection sites: abdomen, thigh, upper arm Store reconstituted solution in refrigerator Refrigeration is required after reconstitution Shelf life in fridge : typically 28-30 days after reconstitution Room temperature stability is limited, see tirzepatide room temperature guidelines Retatrutide administration Retatrutide is currently available only as a research compound in lyophilized powder form
For a 10mg vial, adding 1mL of bacteriostatic water creates a 10mg/mL concentration that works well across the full dose escalation range from 2mg (20 units) to 8mg (80 units)
Some reports screening large numbers of patients have shown signals of more unusual side effects such as nonarteritic anterior ischemic optic neuropathy and suicidal ideation in small numbers of patients prescribed semaglutide
